查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948345

2026年全球組織微陣列市場報告

Tissue Microarray Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，組織晶片市場規模快速成長，預計將從2025年的131.1億美元成長到2026年的146.8億美元，複合年成長率達12.0%。過去幾年的成長可歸因於癌症研究活動的拓展、免疫組織化學技術的日益普及、學術病理學研究的擴展、對生物標記檢驗工具需求的增加以及石蠟包埋組織樣本的可獲得性。

預計未來幾年組織晶片市場將快速成長，到2030年市場規模將達到236.1億美元，複合年成長率（CAGR）為12.6%。預測期內的成長要素包括：精準腫瘤學研究投資的增加、數位病理解決方案的日益普及、轉化研究的進展、對多組體學分析需求的成長以及組織晶片在藥物研發中應用的不斷廣泛。預測期內的關鍵趨勢包括：高通量組織分析平台的廣泛應用、多重免疫組化技術的日益普及、對標準化組織晶片的需求不斷成長、自動化組織晶片構建技術的日益普及以及與分子診斷領域合作的加強。

未來幾年，對個人化醫療日益成長的需求預計將推動組織晶片市場的成長。個人化醫療根據患者的個別特徵客製化治療方案，提供更精準有效的照護。組織晶片在個人化醫療中用於同時分析多個組織樣本，從而實現快速高效的生物標記評估，為個人化治療提供依據。例如，根據美國非營利組織個人化醫療聯盟（Personalized Medicine Coalition）2024年2月發布的消息，美國食品藥物管理局（FDA）在2023年核准了16種針對罕見疾病患者的新型個人化療法，較2022年核准的6種顯著增加。這種對個人化醫療日益成長的需求正在推動組織晶片市場的成長。

組織晶片市場的主要企業正專注於微陣列平台等先進解決方案，以提高高通量組織分析的準確性和效率。微陣列平台是一種能夠在小面積表面上同時分析多個基因和其他生物分子的技術，從而促進基因和表現研究。例如，2023年6月，西班牙海洋醫院（Hospital del Mar）的醫學研究機構MARGenomics推出了Applied Biosystems GeneChip 3000 Dx v2，這是一款由卡洛斯三世健康研究所（ISCIII）和歐盟「下一代歐盟」（Next Generation EU）舉措資助的先進微陣列平台。該系統是歐洲和美國首個獲得診斷用途監管核准的微陣列平台，並已獲得體外診斷醫療設備（IVD-R）認證。它提供多種功能，包括基因組和表達微陣列。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球組織晶片市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧與自主智慧
    • 物聯網 (IoT)、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 高通量組織分析平台的使用日益增多
    • 多重免疫組織化學技術的應用日益廣泛
    • 對標準化組織晶片的需求日益成長
    • 擴展自動化組織微陣列構建
    • 加強與分子診斷領域的合作

第5章 終端用戶產業市場分析

  • 製藥和生物技術公司
  • 研究所
  • 醫院
  • 學術研究機構
  • 診斷檢查室

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球組織微陣列市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球組織晶片市場規模、對比及成長率分析
  • 全球組織微陣列市場表現：規模與成長，2020-2025年
  • 全球組織晶片市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球潛在市場總量（TAM）

第9章 市場細分

  • 按類型
  • 免疫組織化學、螢光雜合反應、冷凍組織晶片和其他類型
  • 透過技術
  • 基於免疫組織化學（IHC）的檢測、原位雜合反應（ISH）技術、數位病理學和影像分析、組織晶片建構技術、訊號檢測和視覺化技術
  • 透過使用
  • 腫瘤學研究和生物標記檢驗、藥物發現和開發、轉化和臨床研究、蛋白質表達和定位分析、基因和RNA表達分析（基於組織）、比較病理學和毒理學研究
  • 最終用戶
  • 製藥和生物技術公司、研究機構、醫院
  • 按類型細分：免疫組織化學
  • 自動化免疫組織化學、手工免疫組織化學、多重免疫組織化學
  • 依類型進行亞分割：螢光雜合反應（FISH）
  • 單色魚、多色魚、DNA魚
  • 按類型細分：冷凍組織晶片
  • 冷凍組織微陣列、速凍組織陣列
  • 按類型細分：其他類型
  • RNA原位雜合反應，石蠟包埋組織晶片

第10章 區域與國家分析

  • 全球組織晶片市場：區域分析、預測（2020-2025年、2025-2030年預測、2035年預測）
  • 全球組織晶片市場：國家、效能與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 組織微陣列市場：競爭格局及市場佔有率（2024年）
  • 組織微陣列市場：公司估值矩陣
  • 組織晶片市場：公司概況
    • BioIVT LLC
    • BioChain Institute Inc.
    • Creative Bioarray Co.
    • 3DHISTECH Ltd.
    • OriGene Technologies Inc.

第37章：其他領先和創新企業

  • Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年組織微陣列市場：提供新機會的國家
  • 2030年組織微陣列市場：新興細分市場機會
  • 組織微陣列市場展望（2030 年）：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MTMIC01_G26Q1

A tissue microarray is a high-throughput technology that enables comprehensive analysis of antigen expression across numerous tissues and cells in a single experiment, typically using paraffin blocks or formalin. It allows for the simultaneous assessment of protein expression in multiple tissue samples.

The primary types of tissue microarrays include immunohistochemistry, fluorescent in situ hybridization, frozen tissue array, and other variants. Immunohistochemistry (IHC) is a technique used to diagnose certain types of cancer, such as mesothelioma, by employing a visual marker to locate antigens in biopsy tissue. Various technologies such as DNA microarrays, polymerase chain reaction (PCR), next-generation sequencing, northern blotting, western blotting, and others are utilized for applications in oncology, gene expression profiling, single nucleotide polymorphism (SNP) detection, double-stranded B-DNA microarrays, comparative genomic hybridization, sequencing bioinformatics, and more. These technologies find applications across different end-users, including pharmaceutical and biotechnological companies, research organizations, and hospitals.

Tariffs are influencing the tissue microarray market by increasing costs of imported laboratory instruments, microarray construction systems, reagents, and imaging equipment. Research institutions and pharmaceutical companies in North America and Europe are most affected due to dependence on imported precision tools, while Asia-Pacific faces higher costs for advanced research infrastructure. These tariffs are raising operational expenses and slowing laboratory upgrades. At the same time, they are supporting domestic production of laboratory equipment and fostering regional research supply chains.

The tissue microarray market research report is one of a series of new reports from The Business Research Company that provides tissue microarray market statistics, including tissue microarray industry global market size, regional shares, competitors with a tissue microarray market share, detailed tissue microarray market segments, market trends and opportunities, and any further data you may need to thrive in the tissue microarray industry. This tissue microarray market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tissue microarray market size has grown rapidly in recent years. It will grow from $13.11 billion in 2025 to $14.68 billion in 2026 at a compound annual growth rate (CAGR) of 12.0%. The growth in the historic period can be attributed to growing cancer research activities, increasing adoption of immunohistochemistry techniques, expansion of academic pathology research, rising demand for biomarker validation tools, availability of paraffin-embedded tissue samples.

The tissue microarray market size is expected to see rapid growth in the next few years. It will grow to $23.61 billion in 2030 at a compound annual growth rate (CAGR) of 12.6%. The growth in the forecast period can be attributed to increasing investments in precision oncology research, rising adoption of digital pathology solutions, expansion of translational research initiatives, growing demand for multi-omics analysis, increasing use of tissue microarrays in drug discovery. Major trends in the forecast period include increasing use of high-throughput tissue analysis platforms, rising adoption of multiplex immunohistochemistry, growing demand for standardized tissue arrays, expansion of automated tissue microarray construction, enhanced integration with molecular diagnostics.

The growing demand for personalized medicine is expected to drive growth in the tissue microarray market in the coming years. Personalized medicine customizes medical treatment based on individual patient characteristics to deliver more precise and effective care. Tissue microarrays are used in personalized medicine to analyze multiple tissue samples simultaneously, enabling rapid and efficient biomarker assessment for tailored patient treatments. For example, in February 2024, the Personalized Medicine Coalition, a US-based nonprofit organization, reported that the US FDA approved 16 new personalized treatments for rare disease patients in 2023, up significantly from six approvals in 2022. Thus, the growing demand for personalized medicine is fueling growth in the tissue microarray market.

Major companies operating in the tissue microarray market are focusing on advanced solutions, such as microarray platforms to enhance precision and efficiency in high-throughput tissue analysis. A microarray platform is a technology that allows for simultaneous analysis of multiple genes or other biomolecules on a small surface, facilitating genetic and expression studies. For instance, in June 2023, MARGenomics, a Spain-based hospital del Mar medical research institute, launched the Applied Biosystems GeneChip 3000 Dx v2, an advanced microarray platform funded by the Carlos III Health Institute (ISCIII) and the European Union's NextGenerationEU initiative. It is the inaugural microarray platform in both Europe and the United States to receive regulatory approval for diagnostic purposes, attaining IVD-R (In Vitro Diagnosis Regulation) certification. The system boasts diverse functionalities, encompassing genomic and expression microarrays.

In May 2024, Bruker Corporation, a US-based provider of high-performance scientific instruments and analytical solutions, acquired NanoString Technologies for approximately USD 392.6 million. Through this acquisition, Bruker aims to expand its spatial biology and transcriptomics capabilities, strengthen its position in high-plex tissue analysis, and enhance its technology portfolio for advanced tissue-based and translational research workflows. NanoString Technologies, also US-based, provides spatial transcriptomics, single-cell imaging, and gene-expression analysis platforms widely used in whole-tissue and tissue-microarray research applications.

Major companies operating in the tissue microarray market are BioIVT LLC, BioChain Institute Inc., Creative Bioarray Co., 3DHISTECH Ltd., OriGene Technologies Inc., Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

North America was the largest region in the tissue microarray market in 2025. Asia-Pacific is expected to be the fastest-growing region in the tissue microarray market report during the forecast period. The regions covered in the tissue microarray market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the tissue microarray market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tissue microarray market consists of sales of molds, needles, and tissue punches. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tissue Microarray Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses tissue microarray market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tissue microarray ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The tissue microarray market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Immunohistochemistry; Fluorescent In Situ Hybridization; Frozen Tissue Array; Other Types
  • 2) By Technology: Immunohistochemistry (IHC)-Based Detection; In Situ Hybridization (ISH) Technologies; Digital Pathology and Image Analysis; Tissue Microarray Construction Technologies; Signal Detection and Visualization Technologies
  • 3) By Application: Oncology Research and Biomarker Validation; Drug Discovery and Development; Translational and Clinical Research; Protein Expression and Localization Analysis; Gene and RNA Expression Analysis (Tissue-Based); Comparative Pathology and Toxicology Studies
  • 4) By End-User: Pharmaceutical And Biotechnological Companies; Research Organizations; Hospitals
  • Subsegments:
  • 1) By Immunohistochemistry: Automated Immunohistochemistry; Manual Immunohistochemistry; Multiplex Immunohistochemistry
  • 2) By Fluorescent In Situ Hybridization (FISH): Single-Color FISH; Multi-Color FISH; DNA FISH
  • 3) By Frozen Tissue Array: Tissue Microarray from Frozen Samples; Snap-Frozen Tissue Array
  • 4) By Other Types: RNA In Situ Hybridization; Paraffin-Embedded Tissue Array
  • Companies Mentioned: BioIVT LLC; BioChain Institute Inc.; Creative Bioarray Co.; 3DHISTECH Ltd.; OriGene Technologies Inc.; Bio SB Inc.; ProteoGenex Inc.; US Biomax Inc.; AMS Biotechnology Ltd.; TissueArray.Com LLC; Pantomics Inc.; Zyagen Inc.; Asterand Bioscience; Indivumed GmbH; PrecisionMed Inc.; Conversant Bio AB; RayBiotech Life Inc.; Novus Biologicals LLC; Tristar Group; iSpecimen Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Tissue Microarray Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Tissue Microarray Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Tissue Microarray Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Tissue Microarray Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics And Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data And Cybersecurity
    • 4.1.3 Industry 4.0 And Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence And Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure And Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Use Of High-Throughput Tissue Analysis Platforms
    • 4.2.2 Rising Adoption Of Multiplex Immunohistochemistry
    • 4.2.3 Growing Demand For Standardized Tissue Arrays
    • 4.2.4 Expansion Of Automated Tissue Microarray Construction
    • 4.2.5 Enhanced Integration With Molecular Diagnostics

5. Tissue Microarray Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical And Biotechnological Companies
  • 5.2 Research Organizations
  • 5.3 Hospitals
  • 5.4 Academic Research Institutes
  • 5.5 Diagnostic Laboratories

6. Tissue Microarray Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Tissue Microarray Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Tissue Microarray PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Tissue Microarray Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Tissue Microarray Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Tissue Microarray Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Tissue Microarray Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Tissue Microarray Market Segmentation

  • 9.1. Global Tissue Microarray Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunohistochemistry, Fluorescent In Situ Hybridization, Frozen Tissue Array, Other Types
  • 9.2. Global Tissue Microarray Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immunohistochemistry (IHC)-Based Detection, In Situ Hybridization (ISH) Technologies, Digital Pathology and Image Analysis, Tissue Microarray Construction Technologies, Signal Detection and Visualization Technologies
  • 9.3. Global Tissue Microarray Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Research and Biomarker Validation, Drug Discovery and Development, Translational and Clinical Research, Protein Expression and Localization Analysis, Gene and RNA Expression Analysis (Tissue-Based), Comparative Pathology and Toxicology Studies
  • 9.4. Global Tissue Microarray Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical And Biotechnological Companies, Research Organizations, Hospitals
  • 9.5. Global Tissue Microarray Market, Sub-Segmentation Of Immunohistochemistry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Automated Immunohistochemistry, Manual Immunohistochemistry, Multiplex Immunohistochemistry
  • 9.6. Global Tissue Microarray Market, Sub-Segmentation Of Fluorescent In Situ Hybridization (FISH), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Color FISH, Multi-Color FISH, DNA FISH
  • 9.7. Global Tissue Microarray Market, Sub-Segmentation Of Frozen Tissue Array, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue Microarray from Frozen Samples, Snap-Frozen Tissue Array
  • 9.8. Global Tissue Microarray Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • RNA In Situ Hybridization, Paraffin-Embedded Tissue Array

10. Tissue Microarray Market Regional And Country Analysis

  • 10.1. Global Tissue Microarray Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Tissue Microarray Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Tissue Microarray Market

  • 11.1. Asia-Pacific Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Tissue Microarray Market

  • 12.1. China Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Tissue Microarray Market

  • 13.1. India Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Tissue Microarray Market

  • 14.1. Japan Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Tissue Microarray Market

  • 15.1. Australia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Tissue Microarray Market

  • 16.1. Indonesia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Tissue Microarray Market

  • 17.1. South Korea Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Tissue Microarray Market

  • 18.1. Taiwan Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Tissue Microarray Market

  • 19.1. South East Asia Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Tissue Microarray Market

  • 20.1. Western Europe Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Tissue Microarray Market

  • 21.1. UK Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Tissue Microarray Market

  • 22.1. Germany Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Tissue Microarray Market

  • 23.1. France Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Tissue Microarray Market

  • 24.1. Italy Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Tissue Microarray Market

  • 25.1. Spain Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Tissue Microarray Market

  • 26.1. Eastern Europe Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Tissue Microarray Market

  • 27.1. Russia Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Tissue Microarray Market

  • 28.1. North America Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Tissue Microarray Market

  • 29.1. USA Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Tissue Microarray Market

  • 30.1. Canada Tissue Microarray Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Tissue Microarray Market

  • 31.1. South America Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Tissue Microarray Market

  • 32.1. Brazil Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Tissue Microarray Market

  • 33.1. Middle East Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Tissue Microarray Market

  • 34.1. Africa Tissue Microarray Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Tissue Microarray Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Tissue Microarray Market Regulatory and Investment Landscape

36. Tissue Microarray Market Competitive Landscape And Company Profiles

  • 36.1. Tissue Microarray Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Tissue Microarray Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Tissue Microarray Market Company Profiles
    • 36.3.1. BioIVT LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. BioChain Institute Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Creative Bioarray Co. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. 3DHISTECH Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. OriGene Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Tissue Microarray Market Other Major And Innovative Companies

  • Bio SB Inc., ProteoGenex Inc., US Biomax Inc., AMS Biotechnology Ltd., TissueArray.Com LLC, Pantomics Inc., Zyagen Inc., Asterand Bioscience, Indivumed GmbH, PrecisionMed Inc., Conversant Bio AB, RayBiotech Life Inc., Novus Biologicals LLC, Tristar Group, iSpecimen Inc.

38. Global Tissue Microarray Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Tissue Microarray Market

40. Tissue Microarray Market High Potential Countries, Segments and Strategies

  • 40.1 Tissue Microarray Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Tissue Microarray Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Tissue Microarray Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer